Partner news
News
Partner news
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
Read full storyPartner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyPartner news
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Read full storyJNJ Press releases
Janssen Announces Collaboration with UC Berkeley, UCSF to Expand Data Science Research in Healthcare
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
Read full storyPartner news
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science
Read full storyJNJ Press releases
Johnson & Johnson Innovation Opens JLABS @ NYC in Collaboration with New York State and the New York Genome Center
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge
Read full storyPartner news
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Read full storyPartner news
E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders
Read full storyJNJ Press releases